welcome
Reuters

Reuters

Health

Health

Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Reuters
Summary
Nutrition label

77% Informative

Swiss generic drug manufacturer Sandoz says it has filed an antitrust lawsuit against Amgen .

Sandoz alleges Amgen blocked competition from more cost-effective biosimilar competitors.

Amgen did not immediately reply to a request for comment.

In 2024 , Enbrel generated $3.3 billion in revenue in the United States .

VR Score

84

Informative language

90

Neutral language

45

Article tone

formal

Language

English

Language complexity

73

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links